おすすめの製品
詳細
Our monodisperse non-porous silica particles have a uniform particle size of 40 µm and a narrow size distribution. Furthermore, these particles are non-porous, meaning they do not contain any internal void spaces. This feature renders their surfaces impermeable to fluids and gases. Additionally, their monodispersity contributes to excellent dispersion properties, allowing them to disperse evenly and maintain stability in a range of solvents, suspensions, or matrices.
アプリケーション
Monodispersed non-porous silica particles find use in various applications such as fillers or additives in composites, coatings, paints, and polymers to enhance mechanical properties or provide unique functionalities. Additionally, these particles find utility in diagnostics, drug delivery systems, sensors, catalysis, and environmental remediation. Their tailored size, uniformity, and stable surfaces contribute to their effectiveness in these applications. The silica particle surface exhibits a highly modifiable chemistry that allows for easy passive functionalization with a variety of biomolecules. The silica particles can also be modified with different functional groups, which can serve as a scaffold for the covalent attachment of biological components such as dextran, antibodies, DNA, or peptides.,
保管分類コード
11 - Combustible Solids
WGK
nwg
引火点(°F)
Not applicable
引火点(℃)
Not applicable
適用法令
試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。
労働安全衛生法名称等を表示すべき危険物及び有害物
名称等を表示すべき危険物及び有害物
労働安全衛生法名称等を通知すべき危険物及び有害物
名称等を通知すべき危険物及び有害物
Jan Code
938254-2G:
938254-BULK:
938254-VAR:
最新バージョンのいずれかを選択してください：
Ja-Yeon Kim et al.
Scientific reports, 7(1), 14566-14566 (2017-11-08)
Nonporous silica nanoparticles (SiNPs) are promising drug carrier platforms for intraocular drug delivery. In this study, we investigated the safety of three different sizes of SiNPs (50, 100, and 150 nm) in a human corneal endothelial cell (HCEC) line, B4G12. The
Sean E Lehman et al.
Langmuir : the ACS journal of surfaces and colloids, 32(3), 731-742 (2015-12-31)
Understanding complex chemical changes that take place at nano-bio interfaces is of great concern for being able to sustainably implement nanomaterials in key applications such as drug delivery, imaging, and environmental remediation. Typical in vitro assays use cell viability as
Li Tang et al.
Nano today, 8(3), 290-312 (2013-09-03)
Nanomedicine, the use of nanotechnology for biomedical applications, has potential to change the landscape of the diagnosis and therapy of many diseases. In the past several decades, the advancement in nanotechnology and material science has resulted in a large number
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら（テクニカルサービス）